Concepedia

Publication | Open Access

Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy

DOIFull Paper Access

349

Citations

31

References

2014

Year

Marius N. Stan, James A. Garrity, Barbara Gisella Carranza Leon, Thapa Prabin, Elizabeth A. Bradley, Rebecca S. Bahn
The Journal of Clinical Endocrinology & Metabolism

Abstract

RTX offered no additional benefit over placebo to our patients with active and moderate to severe GO and carried with it non-negligible adverse effects.

References

YearCitations

Page 1